Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in synthetic biology by completing the creation of the final chromosome in the ...

The research teams at LV Prasad Eye Institute under the Centre for Ocular Regeneration (CORE) at the Brien Holden Research Centre, organized the second edition of the ‘Future is Here’.

In recent transactions reported to the Securities and Exchange Commission, Gerhard Prante, a director at Cibus, Inc. (NASDAQ:CBUS), sold a total of 2,300 shares of the company's Class A Common Stock.

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common ...

The field of cancer research is rapidly evolving, with a growing focus on the intersection of cancer immunology, gene editing, and epigenetics. This ...

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...